Medicinova (MNOV) Interest & Investment Income (2017 - 2025)
Medicinova's (MNOV) quarterly Interest & Investment Income came in at $301876.0 in Q4 2025, down 22.61% year-on-year from $390096.0 in Q4 2024, and down 11.43% on a QoQ basis from $340850.0 in Q3 2025.
Medicinova (MNOV) Interest & Investment Income (2017 - 2025) Analysis & Trends
Medicinova (MNOV) has 9 years of Interest & Investment Income data on file, last reported at $301876.0 in Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 22.61% year-over-year to $301876.0 in Q4 2025; TTM through Dec 2025 was $1.3 million, a 21.97% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 21.97% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $301876.0, down from $340850.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for MNOV reached as high as $509046.0 in Q1 2023 and fell as low as $34338.0 in Q2 2021.
- Historically, Interest & Investment Income has averaged $288128.0 across 5 years, with a median of $338480.5 in 2025.
- Across the five-year window, Interest & Investment Income plunged 83.58% in 2021 and jumped 1263.31% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $36467.0 in 2021, then soared by 1071.76% to $427304.0 in 2022, then rose by 2.1% to $436265.0 in 2023, then fell by 10.58% to $390096.0 in 2024, then declined by 22.61% to $301876.0 in 2025.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $301876.0 in Q4 2025, $340850.0 in Q3 2025, and $324955.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Medicinova | 64.76 Mn | 64.76 Mn | 4,754.00 | 301,876.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 301,876.00 |
| Sep 30, 2025 | 340,850.00 |
| Jun 30, 2025 | 324,955.00 |
| Mar 31, 2025 | 336,111.00 |
| Dec 31, 2024 | 390,096.00 |
| Sep 30, 2024 | 447,847.00 |
| Jun 30, 2024 | 435,351.00 |
| Mar 31, 2024 | 397,510.00 |
| Dec 31, 2023 | 436,265.00 |
| Sep 30, 2023 | 437,934.00 |
| Jun 30, 2023 | 451,420.00 |
| Mar 31, 2023 | 509,046.00 |
| Dec 31, 2022 | 427,304.00 |
| Sep 30, 2022 | 253,755.00 |
| Jun 30, 2022 | 91,275.00 |
| Mar 31, 2022 | 37,339.00 |
| Dec 31, 2021 | 36,467.00 |
| Sep 30, 2021 | 36,153.00 |
| Jun 30, 2021 | 34,338.00 |
| Mar 31, 2021 | 36,668.00 |